Procter & Gamble Health | PGHL | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in June. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2016
2017
2018
2020
2021
Net Income
Net Income
1,102
1,522
11,376
3,549
2,333
Cash flow Operating Act...
Cash flow Operating Activities
1,070537-1,3042,3542,473
Investments in PPE
Investments in PPE
-317-303-267-233-526
Cash flow Investing Act...
Net cash used for Investment Activities
-750-47612,6971,646-323
Dividend Paid
Dividend Paid
1502203018,8343,818
Cash flow Financing Act...
Net cash provided by Financing Activities
-150-220-301-8,834-3,866
Cash at beginning of period
Cash at beginning of period
9226310311,1916,357
Cash at end of period
Cash at end of period
26310311,1966,3574,641
Free Cash Flow
Free Cash Flow
754
234
-1,571
2,121
1,947